House Insurance Committee reports House Bill 4464; PhRMA witness outlines concerns about 340B, PBMs

The Michigan House Insurance Committee reported House Bill 4464 with a recommendation that it pass after a motion to reconsider and a second roll call; the final committee vote was 10-0 in favor. The panel also heard a presentation from Leslie Wood of the Pharmaceutical Research and Manufacturers of America about prescription drug pricing, pharmacy benefit managers and the federal 340B Drug Pricing Program.

The committee's initial motion to report House Bill 4464 with a recommendation that it pass was made by Representative Aragona and passed on a first roll call (recorded as 9 yays, 0 nays). Representative Carter later moved to reconsider that vote; the motion to reconsider passed (recorded as 10 yays, 0 nays). Representative Aragona renewed the motion to report HB 4464, and the committee again recorded a unanimous roll-call vote in favor (10 yays, 0 nays). The clerk recorded the final outcome as “House Bill 4464 is reported with recommendation.”

During the meeting the committee received a…